PRO-DEX, INC. Option Indexed to Issuer's Equity, Strike Price
PRO-DEX, INC. (PDEX) reported Option Indexed to Issuer's Equity, Strike Price of $0.68 per share for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Notes
us-gaap:OptionIndexedToIssuersEquityStrikePrice1 · last filed 2024-09-05
- PRO-DEX, INC. option indexed to issuer's equity, strike price for the quarter ending 2023-09-30 was $0.68.
- PRO-DEX, INC. option indexed to issuer's equity, strike price for fiscal 2023 was $0.69, a 56.88% decline from fiscal 2022.
- PRO-DEX, INC. option indexed to issuer's equity, strike price for fiscal 2022 was $1.60.
| Period end | Option Indexed to Issuer's Equity, Strike Price 3 month | Option Indexed to Issuer's Equity, Strike Price 12 month |
|---|---|---|
| 2023-09-30 | $0.68 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $0.69 10-K · filed 2024-09-05 | |
| 2022-06-30 | $1.60 10-K · filed 2023-10-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |